All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the use(s) under investigation.
The study is conducted to improve knowledge about the epidemiology of Lipoprotein(a) in patients with established cardiovascular disease (CVD).
Cardiovascular Disease and Lipoprotein(a)
Apr 01, 2019
Jul 30, 2021
18 Years - 80 Years (Adult, Older Adult)
Blood draw for Lp(a)
Collect sample for Lipoprotein(a) testing
Signed informed consent
Established CVD defined as one of the following:
History of a myocardial infarction (MI) ≥3 months and ≤10 years before the study visit
History of ischemic stroke ≥ 3 months and ≤ 10 years before the study visit
Symptomatic PAD (intermitted claudication with ankle-brachial index ≤0.90 and/or lower limb amputation or re-vascularization due to lower limb ischemia
- Patients currently enrolled in clinical studies with investigational drugs